A Novel Composite Endpoint of Toxicity-Free, Progression-Free Survival (TPFS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma Aditi Saha,Razan Mohty,Junmin Whiting, Kristen Flores,Jongphil Kim,Taiga Nishihori,Julio C Chavez,Farhad Khimani,Doris K. Hansen,Fabiana Perna,Hien Liu,Bijal D. Shah,Marian Dam,Muhammad Jaffer,Sepideh Mokhtari,Hany Elmariah,Rawan Faramand,Christina A Bachmeier,Nelli Bejanyan,Frederick L. LockeBlood（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
